Beta-Defensin-1 vs Daptomycin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Human beta-defensin-1 (HBD-1) is a constitutively expressed antimicrobial peptide produced by epithelial cells of the skin, respiratory tract, and genitourinary system. Unlike inducible defensins, HBD-1 is present at steady-state levels as a component of basal innate immune defen...
Calculate Beta-Defensin-1 dose →Daptomycin (Cubicin) is a cyclic lipopeptide antibiotic from Streptomyces roseosporus, FDA-approved in 2003. It has a novel mechanism of action distinct from all other approved antibiotics: calcium-dependent insertion into bacterial membranes followed by channel formation and rap...
Calculate Daptomycin dose →| Parameter | Beta-Defensin-1 | Daptomycin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | FDA Approved |
| Half-Life | Hours | 8-9 hours |
| Typical Dose | N/A (endogenous) | 4-6 mg/kg IV once daily (skin); 6-10 mg/kg IV once daily (bacteremia) |
| Frequency | Constitutive | Once daily IV |
| Route | Endogenous | IV |
| FDA Status | Not approved | Approved (MRSA skin, bacteremia, right-sided endocarditis, 2003) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.